Bernard Munos

Bernard Munos

Bernard Munos's picture
Bernard Munos studies pharmaceutical innovation, what causes it and how to get more of it. Several of his papers, published in Nature & Science have helped stimulate a rethinking of the industry business model. In 2012, FiercePharma named him one of the 25 most influential people in biopharma. In 2013, he became a Senior Fellow at FasterCures (a center of the Milken Institute). Besides doing research, he spent a lot of time helping organizations – big, small, public, private, US and non-US – become better innovators. He learned his trade in the 30 years he spent in the industry at Eli Lilly. Before that, he trained as an animal scientist in France and earned additional degrees in business and economics from Stanford and UC-Davis. Bernard serves on various boards and advisory bodies, including at NCATS, the Institute of Medicine, Glenmark Pharmaceuticals, think tanks and foundations.

Latest posts from Bernard:

Column

Can Patient Centricity Help Drive...

Sep 10, 2015

A patient-driven R&D model is able to deliver the same results much faster,...

Column

Breakthrough science, not safe...

Apr 7, 2015

If we want innovation we must be bolder at what we do, Bernard Munos argues in...